Stamatios Aslanis

ORCID: 0000-0001-9407-0541
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Ocular Infections and Treatments
  • Retinal Imaging and Analysis
  • Ocular Oncology and Treatments
  • Glaucoma and retinal disorders

S:t Eriks Ögonsjukhus
2021-2022

Since July 2021, a worldwide shortage of verteporfin (Visudyne®) occurred: an essential medicine required for photodynamic therapy (PDT). PDT with has broad range indications in ophthalmology, including chronic central serous chorioretinopathy, polypoidal choroidal vasculopathy and haemangioma. For these disorders, is either the first-choice treatment or regarded as major option.A questionnaire was sent to key opinion leaders field medical retina throughout world, assess role their country...

10.1111/aos.15148 article EN Acta Ophthalmologica 2022-04-06

To investigate the recurrence rate of active macular neovascularization in patients with neovascular age-related degeneration (nAMD) previously followed up a treat-and-extend (TE) regimen which treatment had been stopped because disease stability.Prospective cohort study.One hundred five nAMD TE treated aflibercept injections.All dry macula on 3 consecutive visits 12 weeks apart were eligible to participate study. Patients examined at baseline and then monitored for 4, 6, 8, 10, months after...

10.1016/j.oret.2021.03.010 article EN cc-by Ophthalmology Retina 2021-03-27
Coming Soon ...